Deploying capital into Greater China real assets and growth-stage technology, Yiheng Capital Management targets cross-border co-investments and control and minority stakes across real estate, logistics, renewable energy, and SaaS platforms. The firm combines balance-sheet financing with structured equity to support operational scale-ups and asset-light rollups for institutional and family-office clients. Portfolio activity emphasizes cash-flow generation, asset optimization, and follow-on capital for winners; fundraising and exits leverage strategic corporate partnerships and domestic secondary channels. Investment team experience spans private equity, asset management, and project finance, with allocation discipline toward ESG-aligned infrastructure and recurring-revenue businesses that offer resilient return profiles.
Deploying capital into Greater China real assets and growth-stage technology, Yiheng Capital Management targets cross-border co-investments and control and minority stakes across real estate, logistics, renewable energy, and SaaS platforms. The firm combines balance-sheet financing with structured equity to support operational scale-ups and asset-light rollups for institutional and family-office clients. Portfolio activity emphasizes cash-flow generation, asset optimization, and follow-on capital for winners; fundraising and exits leverage strategic corporate partnerships and domestic secondary channels. Investment team experience spans private equity, asset management, and project finance, with allocation discipline toward ESG-aligned infrastructure and recurring-revenue businesses that offer resilient return profiles.
Focuses on Greater China real assets and growth-stage technology, deploying balance-sheet financing and structured equity into cross-border co‑investments and both control and minority stakes across real estate, logistics, renewable energy and SaaS. The firm prioritizes cash‑flow generation, asset optimization and asset‑light rollups, underwriting with a bias toward ESG‑aligned infrastructure and recurring‑revenue models. Capital allocation mixes strategic direct investments, follow‑on reserves and partner-led exits to deliver resilient returns for institutional and family‑office clients, leveraging project finance expertise and domestic secondary channels.
Focuses on Greater China real assets and growth-stage technology, deploying balance-sheet financing and structured equity into cross-border co‑investments and both control and minority stakes across real estate, logistics, renewable energy and SaaS. The firm prioritizes cash‑flow generation, asset optimization and asset‑light rollups, underwriting with a bias toward ESG‑aligned infrastructure and recurring‑revenue models. Capital allocation mixes strategic direct investments, follow‑on reserves and partner-led exits to deliver resilient returns for institutional and family‑office clients, leveraging project finance expertise and domestic secondary channels.
| Trades 492 | Longs Won 255/492 51% | Profit Factor 1.61 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $16.72M |
| Average Win $6.27M | Best Trade (Sep 30) $303.67M | Sharpe Ratio -50.13 |
| Average Loss -$4.19M | Worst Trade (Sep 30) -$61.3M | Z-Score -3.63 (100%) |
| Commissions $0 | Avg. Trade Length 2y 4m 3w 3d | Expectancy $1.23M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | 2.02% | 6.53% | 12.99% | 21.15% | 30.87% | 42.06% | 54.62% | 68.5% | 83.64% |
| Consecutive Losing Trades | 48 | 43 | 38 | 34 | 29 | 24 | 19 | 14 | 10 | 5 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
API Agora Inc. | 725,795 | $2.75M | $3.15M | - | $399,765.19 | 14.52% | -3.444% |
BEAM Beam Therapeutics Inc. | 21,126 | $575,049.72 | $492,658.32 | - | -$82,391.4 | -14.33% | -5.702% |
BILI Bilibili Inc. | 1.49M | $21.78M | $20.9M | - | -$873,308.9 | -4.01% | -2.771% |
BILL Bill Holdings Inc. | 222,820 | $8.53M | $10.11M | - | $1.58M | 18.5% | -3.272% |
BIOA BioAge Labs, Inc. | 170,532 | $4.18M | $843,280.74 | - | -$3.34M | -79.82% | -7.57% |
DBVT Dbv Technologies S.A. Sponsored ADR | 170,142 | $525,738.83 | $1.51M | - | $981,634.22 | 186.72% | -2.75% |
EDU New Oriental Education & Technology Group Inc. | 1,636 | $92,646.68 | $99,419.72 | - | $6,773.04 | 7.31% | +0.696% |
HNGE Hinge Health Inc. | 156,190 | $6.02M | $15.42M | - | $9.4M | 156.04% | -5.936% |
HTHT H World Group Limited American Depositary Receipt | 323,371 | $10.15M | $15M | - | $4.85M | 47.77% | +0.969% |
JD JD.com Inc. | 590,513 | $16.78M | $15.93M | - | -$847,127.66 | -5.05% | -1.515% |
JOYY JOYY Inc. American Depositary Shares | 85,583 | $5M | $7.07M | - | $2.07M | 41.39% | -0.728% |
KYMR Kymera Therapeutics Inc. | 63,440 | $1.74M | $6.69M | - | $4.96M | 285.39% | -2.46% |
NOAH Noah Holdings Ltd. | 6.72M | $214.74M | $48.57M | - | -$166.17M | -77.38% | -1.633% |
PASG Passage Bio Inc. | 86,097 | $811,350.33 | $297,034.65 | - | -$514,315.68 | -63.39% | -4.167% |
PONY Pony AI Inc. | 653,215 | $11.07M | $3.22M | - | -$7.85M | -70.91% | -4.642% |
PSIX Power Solutions International, Inc. | 133,500 | $4.87M | $6.22M | - | $1.35M | 27.73% | -8.001% |
RERE Atrenew Inc. | 3.16M | $9M | $12.3M | - | $3.31M | 36.76% | -1.269% |
SVCO Silvaco Group, Inc. | 906,381 | $4.13M | $5.64M | - | $1.51M | 36.51% | -5.395% |
TAL Tal Education Group | 759,240 | $8.47M | $9.05M | - | $583,595.29 | 6.89% | -4.944% |
TCOM Trip.com Group Limited American Depositary Receipt | 88,112 | $4.39M | $3.53M | - | -$854,685.92 | -19.48% | +0.401% |